1. Stocks
  2. Kiora Pharmaceuticals Inc
  3. Swot
swot-logo

Kiora Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Kiora Pharmaceuticals Inc has 11 Strengths, 7 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Increasing profits every quarter for the past 2 quarters

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter